 ROCKVILLE, Md., Jan. 8, 2021 PRNewswire -- REGENXBIO Inc. Nasdaq: RGNX today announced the pricing of an underwritten public offering of 4,260,000 shares of its common stock at the price of 47.00 per share before underwriting discounts and commissions. The gross proceeds to REGENXBIO... 